Prof. Patrick Forde

Prof. Patrick Forde is Prendergast Professor of Immuno-Oncology at Trinity College Dublin and Consultant Medical Oncologist at St. James Hospital Dublin. His research focuses on the development of immunotherapy for surgically resectable cancer, initially exploring the role of single agent anti-PD-1 as neoadjuvant therapy and later as principal investigator of the CheckMate 816 trial which improved long term survival and led to the approval internationally of neoadjuvant chemo-immunotherapy for stage II-III lung cancer. He continues to lead trials internationally focused on precision immuno-oncology in resectable and advanced cancers